Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

B Escudier; C Porta; P Bono; T Powles; T Eisen; CN Sternberg; JE Gschwend; Giorgi U De; O Parikh; R Hawkins; E Sevin; S Négrier; S Khan; J Diaz; S Redhu; F Mehmud; D. Cella

doi:10.1200/JCO.2013.50.8267

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

B Escudier, C Porta, P Bono, T Powles, T Eisen, CN Sternberg, JE Gschwend, Giorgi U De, O Parikh, R Hawkins, E Sevin, S Négrier, S Khan, J Diaz, S Redhu, F Mehmud, D. Cella

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1412-1418
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	32
Issue number	14
DOIs	https://doi.org/10.1200/JCO.2013.50.8267
Publication status	Published - May 2014

Access to Document

10.1200/JCO.2013.50.8267

Cite this

Escudier, B., Porta, C., Bono, P., Powles, T., Eisen, T., Sternberg, CN., Gschwend, JE., De, G. U., Parikh, O., Hawkins, R., Sevin, E., Négrier, S., Khan, S., Diaz, J., Redhu, S., Mehmud, F., & Cella, D. (2014). Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study. Journal of Clinical Oncology, 32(14), 1412-1418. https://doi.org/10.1200/JCO.2013.50.8267

@article{3350d80975c04bb29b284b65da6bc365,

title = "Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.",

author = "B Escudier and C Porta and P Bono and T Powles and T Eisen and CN Sternberg and JE Gschwend and De, {Giorgi U} and O Parikh and R Hawkins and E Sevin and S N{\'e}grier and S Khan and J Diaz and S Redhu and F Mehmud and D. Cella",

year = "2014",

month = may,

doi = "10.1200/JCO.2013.50.8267",

language = "English",

volume = "32",

pages = "1412--1418",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "14",

}

Escudier, B, Porta, C, Bono, P, Powles, T, Eisen, T, Sternberg, CN, Gschwend, JE, De, GU, Parikh, O, Hawkins, R, Sevin, E, Négrier, S, Khan, S, Diaz, J, Redhu, S, Mehmud, F & Cella, D 2014, 'Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.', Journal of Clinical Oncology, vol. 32, no. 14, pp. 1412-1418. https://doi.org/10.1200/JCO.2013.50.8267

TY - JOUR

T1 - Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

AU - Escudier, B

AU - Porta, C

AU - Bono, P

AU - Powles, T

AU - Eisen, T

AU - Sternberg, CN

AU - Gschwend, JE

AU - De, Giorgi U

AU - Parikh, O

AU - Hawkins, R

AU - Sevin, E

AU - Négrier, S

AU - Khan, S

AU - Diaz, J

AU - Redhu, S

AU - Mehmud, F

AU - Cella, D.

PY - 2014/5

Y1 - 2014/5

U2 - 10.1200/JCO.2013.50.8267

DO - 10.1200/JCO.2013.50.8267

M3 - Article

SN - 1527-7755

VL - 32

SP - 1412

EP - 1418

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14

ER -